Repositioning Canagliflozin for Mitigation of Aluminium Chloride-Induced Alzheimer’s Disease: Involvement of TXNIP/NLRP3 Inflammasome Axis, Mitochondrial Dysfunction, and SIRT1/HMGB1 Signalling DOI Creative Commons
Hemat A. Elariny, Ahmed M. Kabel, Heba Mohammed Refat M. Selim

et al.

Medicina, Journal Year: 2024, Volume and Issue: 60(11), P. 1805 - 1805

Published: Nov. 3, 2024

Background and Objectives: Alzheimer’s disease (AD) is the most common neurodegenerative disorder in world. Due to failure of traditional drugs produce a complete cure for AD, search new safe effective lines therapy has attracted attention ongoing research. Canagliflozin an anti-diabetic agent with proven efficacy treatment neurological disorders which mitochondrial dysfunction, oxidative stress, apoptosis, autophagy play pathophysiological role. Elucidation potential effects different doses canagliflozin on AD induced by aluminium chloride rats exploration molecular mechanisms that may contribute these were primary objectives current study. Materials Methods: In rat model effect three behavioural, biochemical, histopathological alterations was assessed. Results: administered chloride-treated animals dose-dependent normalisation behavioural tests, augmentation antioxidant defence mechanisms, inhibition TXNIP/NLRP3 inflammasome signalling, modulation SIRT1/HMGB1 axis, interference pro-inflammatory pro-apoptotic restoration functions hippocampal tissues approximately baseline values. addition, exhibited interesting ability repress chloride-induced changes brain. Conclusions: The functions, inflammatory pathways, signals open gates towards mitigation pathologic features AD.

Language: Английский

Identification of vilazodone as a novel plasminogen activator inhibitor to overcome Alzheimer's disease through virtual screening, molecular dynamics simulation, and biological evaluation DOI
Wenxiu Sun,

Xuan Sheng,

Peiru Li

et al.

Archiv der Pharmazie, Journal Year: 2024, Volume and Issue: 357(9)

Published: May 30, 2024

Abstract Urokinase‐type plasminogen activator (PLAU), a member of the S1 serine peptidase family in Clan PA, plays crucial role conversion into active plasmin. However, precise PLAU central nervous system remains incompletely elucidated, particularly, relation to Alzheimer's disease (AD). In this study, we successfully identified that could promote cell senescence neurons, indicating it as potential target for AD treatment through systematic approach, which included both bioinformatics analysis and experimental verification. Subsequently, structure‐based virtual screening approach was employed identify inhibitor from Food Drug Administration‐approved drug database. After analyzing docking scores thoroughly examining receptor–ligand complex interaction modes, vilazodone emerges highly promising inhibitor. Additionally, molecular dynamics simulations were performed generate structure between relatively stable PLAU. Of note, exhibited superior cytotoxicity against senescent cells, showing senolytic activity targeting ultimately producing an anti‐AD effect. These findings suggest represent therapeutic strategy AD. Furthermore, investigating inhibitory structural modifications based on may provide valuable insights future development disorders.

Language: Английский

Citations

1

Promoting proteostasis by cAMP/PKA and cGMP/PKG DOI
Md Salim Ahammed, Xuejun Wang

Trends in Molecular Medicine, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 1, 2024

Language: Английский

Citations

1

Recent pharmacological insights on abating toxic protein species burden in neurological disorders: Emphasis on 26S proteasome activation DOI

Mahmoud A. Desouky,

Haidy E. Michel, Doaa A. Elsherbiny

et al.

Life Sciences, Journal Year: 2024, Volume and Issue: 359, P. 123206 - 123206

Published: Nov. 1, 2024

Language: Английский

Citations

0

Rosiridin Protects Against Aluminum Chloride-Induced Memory Impairment via Modulation of BDNF/NFκB/PI3K/Akt Pathway in Rats DOI Creative Commons
Sana S. Alqarni, Muhammad Afzal, Khalid Saad Alharbi

et al.

Medicina, Journal Year: 2024, Volume and Issue: 60(11), P. 1812 - 1812

Published: Nov. 4, 2024

Rosiridin is a monoterpene with outstanding monoamine inhibitory activity that useful to treat depressive episodes and rapid-onset dementia. The current investigation aims evaluate the neurologically protective impact of rosiridin, which opposes aluminum chloride (AlCl

Language: Английский

Citations

0

Repositioning Canagliflozin for Mitigation of Aluminium Chloride-Induced Alzheimer’s Disease: Involvement of TXNIP/NLRP3 Inflammasome Axis, Mitochondrial Dysfunction, and SIRT1/HMGB1 Signalling DOI Creative Commons
Hemat A. Elariny, Ahmed M. Kabel, Heba Mohammed Refat M. Selim

et al.

Medicina, Journal Year: 2024, Volume and Issue: 60(11), P. 1805 - 1805

Published: Nov. 3, 2024

Background and Objectives: Alzheimer’s disease (AD) is the most common neurodegenerative disorder in world. Due to failure of traditional drugs produce a complete cure for AD, search new safe effective lines therapy has attracted attention ongoing research. Canagliflozin an anti-diabetic agent with proven efficacy treatment neurological disorders which mitochondrial dysfunction, oxidative stress, apoptosis, autophagy play pathophysiological role. Elucidation potential effects different doses canagliflozin on AD induced by aluminium chloride rats exploration molecular mechanisms that may contribute these were primary objectives current study. Materials Methods: In rat model effect three behavioural, biochemical, histopathological alterations was assessed. Results: administered chloride-treated animals dose-dependent normalisation behavioural tests, augmentation antioxidant defence mechanisms, inhibition TXNIP/NLRP3 inflammasome signalling, modulation SIRT1/HMGB1 axis, interference pro-inflammatory pro-apoptotic restoration functions hippocampal tissues approximately baseline values. addition, exhibited interesting ability repress chloride-induced changes brain. Conclusions: The functions, inflammatory pathways, signals open gates towards mitigation pathologic features AD.

Language: Английский

Citations

0